Serial Number
98376228
Owner
Envoya Inc.Attorney
Susan G. L. GlovskyFirst Use Date
Aug 20, 2024
Filing Date
Jan 25, 2024
ENVOYER Trademark
Serial Number: 98376228 • Registration: 8096742
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Susan G. L. Glovsky Hamilton, Brook, Smith & Reynolds, P.C.
155 Seaport Blvd.
Boston, MA 02210
United States
Trademark Details
Filing Date
January 25, 2024
Registration Date
January 6, 2026
First Use Anywhere
August 20, 2024
First Use in Commerce
August 20, 2024
Published for Opposition
November 12, 2024
Goods & Services
Gene therapy products, namely, non-lipid polymer based nanoparticles for gene therapy; gene therapy products, namely polymer-based nanoparticles for medical, veterinary and pharmaceutical purposes; nucleic acid-containing products, namely RNA and DNA, for medical or veterinary purposes; gene therapy products for the treatment of cancer, metabolic diseases or disorders, neurodegenerative diseases or disorders, cardiovascular diseases or disorders, infectious diseases, or inflammatory diseases or disorders, namely, non-viral vectors; nanoparticle products for medical or veterinary purposes, namely, non-viral vectors; nanoparticles for medical or veterinary purposes, namely, stabilized non-lipid polymer based nanoparticles; nanoparticles that encapsulate nucleic acids for medical or veterinary purposes; nanoparticles that encapsulate cytotoxic payloads in cells for medical or veterinary purposes
Pharmaceutical research and development; research and development services in the field of pharmaceuticals; gene therapy research and development services; research and development services relating to the delivery of RNA and DNA therapeutics to patients; research and development services in the field of nanoparticles and microparticles; research and development services in the field of nucleic acid-containing particles; research and development services in the field of nucleic acids, proteins, and small molecules delivery; Development of nucleic acids, namely RNA and DNA, for encapsulating nanoparticles for targeted delivery; Research services in the field of nanoparticle characteristics; Research services in the field of microparticle characteristics; research and development services in the field of pharmaceutical preparations for the treatment of disease or disorders; research and development services in the field of pharmaceutical preparations for the treatment of cancer, muscular dystrophy, metabolic diseases or disorders, neurodegenerative diseases or disorders, cardiovascular diseases or disorders, infectious diseases, inflammatory diseases or disorders, rare diseases; scientific and technological services, namely, scientific research, analysis, testing, treatment optimizations in the field of nucleic acids, proteins, and small molecules delivery to human cells; scientific and technological services, namely, scientific research, analysis, testing, treatment optimizations in the field of protein delivery to human cells; Scientific and technological services, namely, research and design relating to scientific and technological services in the field of nucleic acids, proteins, and small molecules therapeutics